| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $7.2M | -14.9% |
| SG&A Expense | $8.7M | +17.3% |
| Operating Income | -$16.0M | +35.3% |
| Pre-tax Income | -$15.6M | +36.5% |
| Income Tax | $0 | +100.0% |
| Net Income | -$15.6M | +35.3% |
| EPS (Basic) | -$7.65 | -2960.0% |
| EPS (Diluted) | $2038891.00 | -97.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.1M | -72.9% |
| Short-term Investments | $12.4M | — |
| Current Assets | $22.6M | -40.2% |
| Total Assets | $22.6M | -40.2% |
| Total Liabilities | $2.4M | -17.4% |
| Stockholders' Equity | $20.2M | -42.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$15.0M | -3.2% |
| Investing Cash Flow | -$12.2M | — |
| Financing Cash Flow | $5K | -100.0% |